Patterns of Inclisiran Use in the Real World: An Analysis of US Databases

CompletedOBSERVATIONAL
Enrollment

37,688

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Atherosclerotic Cardiovascular DiseaseFamilial Hypercholesterolemia
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY